PTC Therapeutics ( ($PTCT) ) has shared an update. On December 29, 2025, PTC Therapeutics, Inc. entered into a second amendment to its Amended and ...

PTC (NASDAQ: PTC) has outperformed the market over the past 10 years by 7.24% on an annualized basis producing an average annual return of 20.37%. Currently, PTC has a market capitalization of $24.39 ...

The stock's fall snapped a four-day winning streak.

I've upgraded PTC Inc. to a Buy at ~$179 per share after strong FQ4 2025 results, robust customer contract growth, and improved shareholder returns. PTC's focus on product lifecycle management, ...

Learn more about whether PTC Therapeutics, Inc. or Zymeworks Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

PTC stock tumbled on Thursday after surging double digits in the previous session on a report that said Autodesk was weighing a bid for the software company.

BOSTON (AP) — BOSTON (AP) — PTC Inc. (PTC) on Wednesday reported fiscal fourth-quarter profit of $354.8 million. On a per-share basis, the Boston-based company said it had profit of $2.94. Earnings, ...

A deal between Autodesk and PTC would have made good strategic sense. The industrial software space is rapidly consolidating as the creation of digital threads and loops using data generated by ...

Apart from the AI Assistant, in June, PTC unveiled the Arena Supply Chain Intelligence (SCI), an embedded, AI-driven solution that continuously monitors evolving supply chain conditions, offering real ...

PTC Inc. recently launched the Arena PLM and QMS AI Engine, a cutting-edge solution designed to bring AI-powered intelligence directly into core product lifecycle and quality work ...

Agentic AI advancements in ServiceMax AI accelerate work order execution and enable improvements in first-time fix rates Agentic AI advancements in Servigistics expand AI-driven intelligence for ...